Metabolic aspects of sleep apnea

Sleep

Volumn 19, Issue 10 SUPPL., 1996, Pages

  Grunstein, Ronald R ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Energy expenditure; Growth hormone; Insulin; Obesity; Serotonin; Sleep apnea

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; INSULIN; SEROTONIN; SOMATOMEDIN C; SOMATOSTATIN; TESTOSTERONE;

CONFERENCE PAPER; DISEASE ASSOCIATION; ENERGY BALANCE; HORMONE RELEASE; HUMAN; INSULIN SENSITIVITY; OBESITY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SLEEP APNEA SYNDROME; WEIGHT GAIN;

EID: 0030431451     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/19.suppl_10.s218     Document Type: Conference Paper

References (14)

1. Grunstein RR. Endocrine and metabolic disturbances in obstructive sleep apnea. In: Saunders NA. Sullivan CE, eds. Sleep and breathing, 2nd edition. New York: Marcel Dekker, 1993.
2. Grunstein RR, Handelsman DJ, Lawrence S, Blackwell C, Caterson ID, Sullivan CE. Neuroendocrine dysfunction in sleep apnea: reversal by nasal continuous positive airway pressure. J Clin Endocrinol Metab 1989;68:352-8.
3. Stewart D, Grunstein RR, Berthon-Jones M. Handelsman DJ, Sullivan CE. Androgen blockade does not affect sleep disordered breathing or chemosensitivity in men with obstructive sleep apnea. Am Rev Respir Dis 1992;146:1389-93.
4. Grunstein RR, Wilcox I, Yang TS, Hedner J. Snoring and sleep apnea in men - association with central obesity and hypertension. Int J Obesity 1993;17:533-40.
5. Grunstein RR, Handelsman DJ, Stewart DA, Sullivan CE. Growth hormone secretion is increased by nasal CPAP treatment of sleep apnea. Am Rev Respir Dis 1993;147:A686.
6. Cistulli P, Grunstein RR, Sullivan CE. Effect of testosterone on upper airway collapsibility during sleep. Am J Respir Crit Care Med 1994;149:530-2.
7. Brooks B, Cistulli PA, Borkman M, et al. Effect of nasal continuous positive airway pressure treatment on insulin sensitivity in patients with Type II diabetes and obstructive sleep apnea. J Clin Endocrinol Metab 1994;79:1681-5.
8. Grunstein RR, Stenlöf K, Hedner J, Sjöstrom L. Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. Int J Obesity 1995;19:410-8.
9. Grunstein RR, Stenlöf K. Hedner J, Sjöstrom L. Impact of self reported sleep apnea symptoms on psycho-social performance in the Swedish Obese Subjects (SOS) Study. Sleep 1995;18: 635-43.
10. Stenlöf K, Grunstein RR, Henning B, Hedner J. Sjöstrom L. Energy expenditure in sleep apnea. Am J Physiol (in press).
11. Van Cauter E, Caufriez A, Kerkofs M, van Onderbergen A, Thorner MO, Copinschi G. Sleep, awakenings, and insulin-like growth factor 1 modulate the growth hormone (GH) secretory response to GH-releasing hormone. J Clin Endocrinol Metab 1992;74:1451-9.
12. Bengtsson B-A, Edén S, Lönn L et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993;76:309-17.
13. Bonnet MH, Berry RB, Arand DL. Metabolism during normal, fragmented and recovery sleep. J Appl Physiol 1991;71:1112-8.
14. Hudgel DW, Gordon EA, Meltzer HY. Abnormal serotenergic stimulation of cortisol production in obstructive sleep apnea. Am J Respir Crit Care Med 1995;152:186-92.